Ocata Therapeutics Inc fka OCAT

[rumper]

OCAT Does Not Inject Stem Cells

OCAT uses stem cells to make RPE cells.

RPE cells are not stem cells, RPE cells are
the bottom layer of the retina.

1.8 Million new cases of dry AMD every year

OCATs fully differentiated Retinal Pigment Epithelia (RPE) cells,
cell-transplants, halts the disease, proven safe in completed
phase 1 FDA Trials. The earliest transplants remains viable after three years.

It works, and it lasts a long time.

Roughly 2500 ophthalmologist MDs in the US, they all
read the Lancet, and can be covered with a sales force
of 20.

The transplant is made with an eye injection, already a
common technique in the medical community.

Even reaching 1% of the new cases each year amounts
to 18Billion. (times 2, two eyes each) 36 billion.

At 100K per eye.

The technology is mind boggling,
and so is the potential market.

http://www.retailroadshow.com/wp/roadshows.asp
(Watch the roadshow again, until you understand what's going on here)